Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| TIKI2 | A6NFA1 | Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B) | Predicted intracellular proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| TLR10 | Q9BXR5 | Toll-like receptor 10 (CD antigen CD290) | 1 | Clinical-translation mediationImmune mediation | 1 | 0.50 | ||||
| TLR2 | O60603 | Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282) | 1 | Diabetes mellitusMelanomaMyelodysplastic syndrome | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| TM222 | Q9H0R3 | Transmembrane protein 222 | Disease related genesHuman disease related genesPredicted membrane proteins | 3 | Other mediation | 1 | 0.50 | |||
| TM237 | Q96Q45 | Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein) | Disease related genesHuman disease related genesPotential drug targets | 4 | Receptor-signaling mediation | 1 | 0.50 | |||
| TM245 | Q9H330 | Transmembrane protein 245 (Protein CG-2) | Predicted membrane proteinsTransporters | 14 | Other mediation | 1 | 0.50 | |||
| TM266 | Q2M3C6 | Transmembrane protein 266 (hTMEM266) (HV1-related protein 1) (HsHVRP1) | Predicted membrane proteins | 4 | Other mediation | 1 | 0.50 | |||
| TMG1 | O14668 | Transmembrane gamma-carboxyglutamic acid protein 1 (Proline-rich gamma-carboxyglutamic acid protein 1) (Proline-rich Gla protein 1) | 1 | Immune mediation | 1 | 0.50 | ||||
| TMM52 | Q8NDY8 | Transmembrane protein 52 | 1 | Other mediation | 1 | 0.50 | ||||
| TMM61 | Q8N0U2 | Transmembrane protein 61 | Predicted membrane proteins | 2 | Other mediation | 1 | 0.50 | |||
| TMM65 | Q6PI78 | Transmembrane protein 65 | Disease related genesPotential drug targetsPredicted membrane proteins | 3 | Other mediation | 1 | 0.50 | |||
| TMPSD | Q9BYE2 | Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease) | 1 | Other mediation | 1 | 0.50 | ||||
| TMTC2 | Q8N394 | Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2) | EnzymesPredicted membrane proteins | 11 | Metabolism mediation | 1 | 0.50 | |||
| TNR11 | Q9Y6Q6 | Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265) | CD markersDisease related genesHuman disease related genes | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| TNR12 | Q9NP84 | Tumor necrosis factor receptor superfamily member 12A (Fibroblast growth factor-inducible immediate-early response protein 14) (FGF-inducible 14) (Tweak-receptor) (TweakR) (CD antigen CD266) | Cancer-related genesCD markersPredicted intracellular proteins | 1 | Solid tumour/cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||
| TNR6 | P25445 | Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Brain cancerCerebral ischaemiaMature T-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| TRAT1 | Q6PIZ9 | T-cell receptor-associated transmembrane adapter 1 (T-cell receptor-interacting molecule) (TRIM) (pp29/30) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| TRDN | Q13061 | Triadin | Disease related genesHuman disease related genesPlasma proteins | 1 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| TRPM7 | Q96QT4 | Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7) [Cleaved into: TRPM7 kinase, cleaved form (M7CK); TRPM7 channel, cleaved form] | Disease related genesEnzymesEssential proteins | 6 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| TS1R3 | Q7RTX0 | Taste receptor type 1 member 3 (Sweet taste receptor T1R3) | G-protein coupled receptorsPredicted membrane proteinsTransporters | 7 | Receptor-signaling mediation | 1 | 0.50 | |||
| TSN16 | Q9UKR8 | Tetraspanin-16 (Tspan-16) (Tetraspanin TM4-B) (Transmembrane 4 superfamily member 16) | Predicted membrane proteins | 4 | Other mediation | 1 | 0.50 | |||
| TTYH1 | Q9H313 | Protein tweety homolog 1 (hTTY1) (Volume-regulated anion channel subunit TTYH1) | Predicted membrane proteinsTransporters | 5 | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.50 | |||
| TXD11 | Q6PKC3 | Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Metabolism mediation | 1 | 0.50 | |||
| TYOBP | O43914 | TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein) | Disease related genesHuman disease related genesPotential drug targets | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | |||
| TYRP2 | P40126 | L-dopachrome tautomerase (DCT) (DT) (EC 5.3.3.12) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2) | Disease related genesEnzymesHuman disease related genes | 1 | Metabolism mediation | 1 | 0.50 |